Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma. (linkinghub.elsevier.com)

Authors: Karapetyan L … Pilon-Thomas S Journal: Cell Med Published: 2026-07-29 DOI: https://doi.org/10.1016/j.medj.2026.101231